Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma

NEXT STORY
Global Microcrystalline Cellulose (MCC) Industry
PREV STORY
North America Airway Clearance System Market (2020 to 2025) – by Type, Application, End-use and Country
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Eight Data Presentations at ECCMID Showcase the Broad Applicability of SCYNEXIS’ Lead Anti-infective Candidate SCY-078

Presentations support SCY-078's potential as a novel treatment for Candida infections including multidrug-resistant strains Favorable ...

author_avatar
NASDAQ Market News

Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

SCYNEXIS Announces Presentations at 2020 IDSOG Virtual Annual Meeting Highlighting Ibrexafungerp’s Potential for the Treatment of Vulvovaginal Candidiasis

author_avatar
NASDAQ Market News